Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rutgers

Showing results (951-960 of 982) with videos related to

Pageof 99
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 6, 2007
Guidelines on the standards for the training of specialised health professionals dealing with breast cancerL Cataliotti, C De Wolf, R Holland, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2023
Differences in IgG autoantibody Fab glycosylation across autoimmune diseasesJana Koers, Rocco Sciarrillo, Ninotska I L Derksen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017G Curigliano, H J Burstein, E P Winer, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2022
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunityLeanne P M van Leeuwen, Corine H GeurtsvanKessel, Pauline M Ellerbroek, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Blood Advances|December 11, 2025
Systematic functional validation of IKAROS variants from patients and laboratory-generated mutationsHye Sun Kuehn, Agustin Alejandro Gil Silva, Natchanun Klangkalya, et al.
Nature Communications|July 21, 2023
Obesity-associated changes in molecular biology of primary breast cancerHa-Linh Nguyen, Tatjana Geukens, Marion Maetens, et al.
BMC Medicine|March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseasesLuuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Pageof 99

Showing results (951-960 of 982) with videos related to

Sort By:
Pageof 99
European Journal of Cancer (Oxford, England : 1990)|February 6, 2007
Guidelines on the standards for the training of specialised health professionals dealing with breast cancerL Cataliotti, C De Wolf, R Holland, et al.
The Journal of Allergy and Clinical Immunology|January 30, 2023
Differences in IgG autoantibody Fab glycosylation across autoimmune diseasesJana Koers, Rocco Sciarrillo, Ninotska I L Derksen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2017
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017G Curigliano, H J Burstein, E P Winer, et al.
The Journal of Prevention of Alzheimer'S Disease|January 12, 2025
Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trialStephen Macfarlane, Timo Grimmer, Ken Teo, et al.
The Journal of Allergy and Clinical Immunology|April 14, 2022
Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunityLeanne P M van Leeuwen, Corine H GeurtsvanKessel, Pauline M Ellerbroek, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 11, 2025
American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert PanelArsene M Mekinian, Sophie Georgin-Lavaille, Marcela A Ferrada, et al.
Blood Advances|December 11, 2025
Systematic functional validation of IKAROS variants from patients and laboratory-generated mutationsHye Sun Kuehn, Agustin Alejandro Gil Silva, Natchanun Klangkalya, et al.
Nature Communications|July 21, 2023
Obesity-associated changes in molecular biology of primary breast cancerHa-Linh Nguyen, Tatjana Geukens, Marion Maetens, et al.
BMC Medicine|March 3, 2022
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseasesLuuk Wieske, Laura Y L Kummer, Koos P J van Dam, et al.
Journal of Autoimmunity|January 9, 2023
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinationsKoos P J van Dam, Luuk Wieske, Eileen W Stalman, et al.
Pageof 99